Based on four small studies, it is concluded that this limited data indicates there is not enough evidence to confirm or refute whether albendazole, given alone or co-administered with DEC or ivermectin, has an effect on lymphatic filariasis.
This Evidence Update was adapted from International Filariasis Review Group (David Addiss, Julia Critchley, Henry Ejere, Paul Garner, Hellen Gelband, Carrol Gamble). Albendazole for lymphatic filariasis (Cochrane Review). In: The Cochrane Library, Issue 1, 2004.
Child Health Series, Effective Health Care Alliance Programme, Liverpool School of Tropical Medicine, 2 pp.